Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP27001.RAAlNMgaz1Vs2HNEGaf8sH1ynSFvzkWrLLg4wyZW-mTKA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP27001.RAAlNMgaz1Vs2HNEGaf8sH1ynSFvzkWrLLg4wyZW-mTKA130_assertion type Assertion NP27001.RAAlNMgaz1Vs2HNEGaf8sH1ynSFvzkWrLLg4wyZW-mTKA130_head.
- NP27001.RAAlNMgaz1Vs2HNEGaf8sH1ynSFvzkWrLLg4wyZW-mTKA130_assertion description "[We found that in hepatocellular carcinomas, in the late glycogen-poor passages (C1I(late)), and in the tumorigenic subline (C1Ict) of C1I cells, and in MH3924A cells the mRNA expression of inhibitor-1 is significantly increased.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP27001.RAAlNMgaz1Vs2HNEGaf8sH1ynSFvzkWrLLg4wyZW-mTKA130_provenance.
- NP27001.RAAlNMgaz1Vs2HNEGaf8sH1ynSFvzkWrLLg4wyZW-mTKA130_assertion evidence source_evidence_curated NP27001.RAAlNMgaz1Vs2HNEGaf8sH1ynSFvzkWrLLg4wyZW-mTKA130_provenance.
- NP27001.RAAlNMgaz1Vs2HNEGaf8sH1ynSFvzkWrLLg4wyZW-mTKA130_assertion SIO_000772 15010824 NP27001.RAAlNMgaz1Vs2HNEGaf8sH1ynSFvzkWrLLg4wyZW-mTKA130_provenance.
- NP27001.RAAlNMgaz1Vs2HNEGaf8sH1ynSFvzkWrLLg4wyZW-mTKA130_assertion wasDerivedFrom ctd_human-20130708 NP27001.RAAlNMgaz1Vs2HNEGaf8sH1ynSFvzkWrLLg4wyZW-mTKA130_provenance.
- NP27001.RAAlNMgaz1Vs2HNEGaf8sH1ynSFvzkWrLLg4wyZW-mTKA130_assertion wasGeneratedBy ECO_0000218 NP27001.RAAlNMgaz1Vs2HNEGaf8sH1ynSFvzkWrLLg4wyZW-mTKA130_provenance.